NCT00035607 - Chemotherapy Related Anemia | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

December 31, 2001

Primary Completion Date

December 31, 2002

Study Completion Date

April 30, 2003

Conditions

AnemiaNon-Myeloid Malignancies

Interventions

DRUG

Darbepoetin alfa SC

Subcutaneous (SC) injection of darbepoetin alfa at 4.5 mcg/kg weekly for weeks 1-6, then 4.5 mcg/kg Q3W

DRUG

Darbepoetin alfa IV

Intravenous administration of darbepoetin alfa at 4.5 mcg/kg weekly for weeks 1-6, then 4.5 mcg/kg Q3W